A STUDY OF TAK-659 IN COMBINATION WITH NIVOLUMAB IN PARTICIPANTS WITH ADVANCED SOLID TUMORS.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
MILLENNIUM PHARMACEUTICALS INC
Cita
A STUDY OF TAK-659 IN COMBINATION WITH NIVOLUMAB IN PARTICIPANTS WITH ADVANCED SOLID TUMORS. (C34003). MILLENNIUM PHARMACEUTICALS INC. 2017-2019. IP:ANA SANTABALLA BERTRÁN.
Portal de investigación